Cargando…

Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework

It is estimated among individuals with type 2 diabetes (T2D) requiring injectable therapies to achieve optimal glycaemic control, one-third are reluctant to initiate therapies, with approximately 80% choosing to discontinue or interrupt injectable regimens soon after commencement. Initiation of inje...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuigan, Karen, Hill, Alyson, McCay, Deirdre, O’Kane, Maurice, Coates, Vivien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012154/
https://www.ncbi.nlm.nih.gov/pubmed/36994326
http://dx.doi.org/10.3389/fcdhc.2021.792634
_version_ 1784906561084194816
author McGuigan, Karen
Hill, Alyson
McCay, Deirdre
O’Kane, Maurice
Coates, Vivien
author_facet McGuigan, Karen
Hill, Alyson
McCay, Deirdre
O’Kane, Maurice
Coates, Vivien
author_sort McGuigan, Karen
collection PubMed
description It is estimated among individuals with type 2 diabetes (T2D) requiring injectable therapies to achieve optimal glycaemic control, one-third are reluctant to initiate therapies, with approximately 80% choosing to discontinue or interrupt injectable regimens soon after commencement. Initiation of injectables is a complex issue, with effectiveness of such treatments undermined by non-adherence or poor engagement. Poor engagement and adherence are attributed to psychological aspects such as individuals’ negative perceptions of injectables, depression, anxiety, feelings of shame, distress and perceived lack of control over their condition. The aim of this study was to describe the development of a structured diabetes intervention to address psychological barriers to injectable treatments among a cohort of those with T2D; conducted within a behavioural change framework. An evidence base was developed to inform on key psychological barriers to injectable therapies. A systematic review highlighted the need for theory-based, structured diabetes education focussed on associated psychological constructs to inform effective, patient-centric provisions to improve injectable initiation and persistence. Findings from the focus groups with individuals who had recently commenced injectable therapies, identified patient-centric barriers to initiation and persistence with injectables. Findings from the systematic review and focus groups were translated via Behavioural Change Wheel (BCW) framework to develop an intervention for people with T2D transitioning to injectable therapies: Overcoming and Removing Barriers to Injectable Treatment in T2D (ORBIT). This article describes how psychological barriers informed the intervention with these mapped onto relevant components, intervention functions and selected behaviour change techniques, and finally aligned with behaviour change techniques. This article outlines the systematic approach to intervention development within the BCW framework; guiding readers through the practical application of each stage. The use of the BCW framework has ensured the development of the intervention is theory driven, with the research able to be evaluated and validated through replication due to the clarity around processes and tasks completed at each stage.
format Online
Article
Text
id pubmed-10012154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100121542023-03-28 Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework McGuigan, Karen Hill, Alyson McCay, Deirdre O’Kane, Maurice Coates, Vivien Front Clin Diabetes Healthc Clinical Diabetes and Healthcare It is estimated among individuals with type 2 diabetes (T2D) requiring injectable therapies to achieve optimal glycaemic control, one-third are reluctant to initiate therapies, with approximately 80% choosing to discontinue or interrupt injectable regimens soon after commencement. Initiation of injectables is a complex issue, with effectiveness of such treatments undermined by non-adherence or poor engagement. Poor engagement and adherence are attributed to psychological aspects such as individuals’ negative perceptions of injectables, depression, anxiety, feelings of shame, distress and perceived lack of control over their condition. The aim of this study was to describe the development of a structured diabetes intervention to address psychological barriers to injectable treatments among a cohort of those with T2D; conducted within a behavioural change framework. An evidence base was developed to inform on key psychological barriers to injectable therapies. A systematic review highlighted the need for theory-based, structured diabetes education focussed on associated psychological constructs to inform effective, patient-centric provisions to improve injectable initiation and persistence. Findings from the focus groups with individuals who had recently commenced injectable therapies, identified patient-centric barriers to initiation and persistence with injectables. Findings from the systematic review and focus groups were translated via Behavioural Change Wheel (BCW) framework to develop an intervention for people with T2D transitioning to injectable therapies: Overcoming and Removing Barriers to Injectable Treatment in T2D (ORBIT). This article describes how psychological barriers informed the intervention with these mapped onto relevant components, intervention functions and selected behaviour change techniques, and finally aligned with behaviour change techniques. This article outlines the systematic approach to intervention development within the BCW framework; guiding readers through the practical application of each stage. The use of the BCW framework has ensured the development of the intervention is theory driven, with the research able to be evaluated and validated through replication due to the clarity around processes and tasks completed at each stage. Frontiers Media S.A. 2021-12-09 /pmc/articles/PMC10012154/ /pubmed/36994326 http://dx.doi.org/10.3389/fcdhc.2021.792634 Text en Copyright © 2021 McGuigan, Hill, McCay, O’Kane and Coates https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Clinical Diabetes and Healthcare
McGuigan, Karen
Hill, Alyson
McCay, Deirdre
O’Kane, Maurice
Coates, Vivien
Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
title Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
title_full Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
title_fullStr Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
title_full_unstemmed Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
title_short Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
title_sort overcoming barriers to injectable therapies: development of the orbit intervention within a behavioural change framework
topic Clinical Diabetes and Healthcare
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012154/
https://www.ncbi.nlm.nih.gov/pubmed/36994326
http://dx.doi.org/10.3389/fcdhc.2021.792634
work_keys_str_mv AT mcguigankaren overcomingbarrierstoinjectabletherapiesdevelopmentoftheorbitinterventionwithinabehaviouralchangeframework
AT hillalyson overcomingbarrierstoinjectabletherapiesdevelopmentoftheorbitinterventionwithinabehaviouralchangeframework
AT mccaydeirdre overcomingbarrierstoinjectabletherapiesdevelopmentoftheorbitinterventionwithinabehaviouralchangeframework
AT okanemaurice overcomingbarrierstoinjectabletherapiesdevelopmentoftheorbitinterventionwithinabehaviouralchangeframework
AT coatesvivien overcomingbarrierstoinjectabletherapiesdevelopmentoftheorbitinterventionwithinabehaviouralchangeframework